Encephalitis, Viral
Recent clinical, regulatory, research and industry developments relating to this disease.
Orchestration of antiviral responses within the infected central nervous system.
What's happening now
An analyst briefing on current research, clinical, regulatory and industry activity surrounding this disease.
Clinical trials
The current development programme across all trial phases.
Research activity
Key research shaping understanding of this disease, combining the latest publications with the most influential evidence.
Major themes1
- Central Nervous System1
Leading journals2
- Cellular & molecular immunology1
- Viruses1
Leading researchers8
- Bourgouin A1
- Busker LM1
- Desforges M1
- Dubé M1
- Dubeau P1
- Gern OL1
- Greimel E1
- Kalinke U1
Affiliations (unnormalised)6
- Hannover Medical School1
- Institute for Experimental Infection Research1
- Laboratory of Neuroimmunovirology1
- Research Centre of the Centre Hospitalier de l'Université de Montréal (CRCHUM)1
- Université de Sherbrooke1
- University of Veterinary Medicine Hannover1
Reference
Authoritative identity, definition & identifiers.
Inflammation of brain parenchymal tissue as a result of viral infection. Encephalitis may occur as primary or secondary manifestation of TOGAVIRIDAE INFECTIONS; HERPESVIRIDAE INFECTIONS; ADENOVIRIDAE INFECTIONS; FLAVIVIRIDAE INFECTIONS; BUNYAVIRIDAE INFECTIONS; PICORNAVIRIDAE INFECTIONS; PARAMYXOVIRIDAE INFECTIONS; ORTHOMYXOVIRIDAE INFECTIONS; RETROVIRIDAE INFECTIONS; and ARENAVIRIDAE INFECTIONS.
- Disease identity & definition — NLM Medical Subject Headings (MeSH), public domain
- Clinical trials — ClinicalTrials.gov (U.S. National Library of Medicine)
- Research activity — Europe PMC (EMBL-EBI) + OpenAlex-derived paper links
- Related entities are derived from literature co-mention (studied together) — associative, not causal.